Lobbying client
GLYCOMIMETICS, INC.
GlycoMimetics, Inc. specializes in small molecule therapeutics
Filings
12
Filed by
1
Reported in-house
—
Reported by firms
$90,000
Reported lobbying by year
The larger of in-house and firm-reported each year, $ thousands
2009 to 2011
Filings
4 filings for 2010, newest first.
| Filing | Filed by | Amount |
|---|---|---|
|
4th Quarter - Report 4th Quarter 2010
|
TARPLIN, DOWNS & YOUNG, LLC | $10,000 reported |
|
3rd Quarter - Report 3rd Quarter 2010
|
TARPLIN, DOWNS & YOUNG, LLC | $10,000 reported |
|
2nd Quarter - Report 2nd Quarter 2010
|
TARPLIN, DOWNS & YOUNG, LLC | $10,000 reported |
|
1st Quarter - Report 1st Quarter 2010
|
TARPLIN, DOWNS & YOUNG, LLC | $10,000 reported |
Filed by
Each firm that has reported for this client, and the client itself where it lobbies in-house, with the reports filed and the amounts they disclose.
| Firm | Reports | Amount |
|---|---|---|
| TARPLIN, DOWNS & YOUNG, LLC | 11 | $90,000 |
Issues lobbied
How many report sections named each issue, counting the current version of each report.
| Issue | Code | Mentions |
|---|---|---|
| Health Issues | HCR | 12 |
| Pharmacy | PHA | 1 |
| Medicare/Medicaid | MMM | 1 |
Support LegiList
This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.
From reports filed under the Lobbying Disclosure Act. Firms report what each client paid them; an organisation lobbying for itself reports its own expenses. Amounts count the current version of each report once.